Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 11951
TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664691(US11952377, Example 19)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664699(US11952377, Example 27)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664698(US11952377, Example 26)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664695(US11952377, Example 23)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664694(US11952377, Example 22)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664681(US11952377, Example 9)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664680(US11952377, Example 8)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664696(US11952377, Example 24)
Affinity DataIC50: 10nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664675(US11952377, Example 3)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664673(US11952377, Example 2)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664677(US11952377, Example 5)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664676(US11952377, Example 4)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664672(US11952377, Example 1)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664683(US11952377, Example 11)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664682(US11952377, Example 10)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664685(US11952377, Example 13)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664684(US11952377, Example 12)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664679(US11952377, Example 7)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664678(US11952377, Example 6)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664690(US11952377, Example 18)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664693(US11952377, Example 21)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664692(US11952377, Example 20)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664687(US11952377, Example 15)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664686(US11952377, Example 14)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664689(US11952377, Example 17)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664688(US11952377, Example 16)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent

TargetADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM664697(US11952377, Example 25)
Affinity DataIC50: 55nMAssay Description:The CD38 enzyme assay was performed as described previously (Becherer, J D, et al. J. Med. Chem. 2015, 58, 7021-7056). Briefly, 200 nL of a dose resp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/27/2024
Entry Details
US Patent